Horak F - Search Results

1

Pharmacodynamic dose finding of dimetindene in a sustained release formulation.

Horak F, Jäger S, Nirnberger G, Berger U, Andresen L, Vix JM, Rehn D. Horak F, et al. Arzneimittelforschung. 1993 Nov;43(11):1193-5. Arzneimittelforschung. 1993. PMID: 8292063 Clinical Trial.

2

Horak FF, Jäger S, Nirnberger G, Berger U, Andresen I, Vix JM, Rehn D. Horak FF, et al. Int Arch Allergy Immunol. 1994;103(3):298-302. doi: 10.1159/000236643. Int Arch Allergy Immunol. 1994. PMID: 7906578 Clinical Trial.

3

Onset and duration of the effects of three antihistamines in current use--astemizole, loratadine and terfenadine forte--studied during prolonged, controlled allergen challenges in volunteers.

Horak F, Jäger S, Berger U. Horak F, et al. J Int Med Res. 1992 Sep;20(5):422-34. doi: 10.1177/030006059202000507. J Int Med Res. 1992. PMID: 1451923 Clinical Trial.

4

Controlled exposure to mite allergen for a dose-finding of dimethindene maleate (DMM).

Horak F, Jäger S, Berger U, Toth J, Nirnberger G, Kyrein HJ, Rehn D, Vix JM. Horak F, et al. Agents Actions. 1994 Jun;41 Spec No:C124-6. doi: 10.1007/BF02007795. Agents Actions. 1994. PMID: 7976797 Clinical Trial.

5

Effects of H1-receptor antagonists on nasal obstruction in atopic patients.

Horak F, Toth J, Jäger S, Berger U. Horak F, et al. Allergy. 1993 May;48(4):226-9. doi: 10.1111/j.1398-9995.1993.tb00720.x. Allergy. 1993. PMID: 8328656 Clinical Trial.

6

Efficacy and tolerability of astemizole-D and Loratadine-D during prolonged, controlled allergen challenge in the Vienna Challenge Chamber.

Horak F, Jäger S, Toth J, Berger U. Horak F, et al. Arzneimittelforschung. 1996 Nov;46(11):1077-81. Arzneimittelforschung. 1996. PMID: 8955868 Clinical Trial.

7

Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.

Kyrein HJ, Horak F, Nirnberger G, Rehn D. Kyrein HJ, et al. Among authors: horak f. Arzneimittelforschung. 1996 Aug;46(8):794-9. Arzneimittelforschung. 1996. PMID: 9125281 Clinical Trial.

8

Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.

Horak F, Berger UE, Menapace R, Toth J, Stübner PU, Marks B. Horak F, et al. Arzneimittelforschung. 1998 Apr;48(4):379-84. Arzneimittelforschung. 1998. PMID: 9608880 Clinical Trial.

9

Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion.

Horak F, Toth J, Marks B, Stübner UP, Berger UE, Jäger S, Burtin B, Duby C. Horak F, et al. Allergy. 1998 Sep;53(9):849-56. doi: 10.1111/j.1398-9995.1998.tb03990.x. Allergy. 1998. PMID: 9788685 Clinical Trial.

10

Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.

Stübner UP, Toth J, Marks B, Berger UE, Burtin B, Horak F. Stübner UP, et al. Among authors: horak f. Arzneimittelforschung. 2001 Nov;51(11):904-10. doi: 10.1055/s-0031-1300135. Arzneimittelforschung. 2001. PMID: 11765592 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters